Disease-Free Survival

Publication Title: 
The Cochrane Database of Systematic Reviews

BACKGROUND: This is the second update of the review first published in the Cochrane Database of Systematic Reviews in 2009, Issue 1. Epithelial ovarian cancer is diagnosed in over 200,000 women worldwide each year. Ten to 20% of women are diagnosed early, when there is still a good possibility of cure. The treatment of early-stage (stage I and IIa) disease involves surgery to remove the disease, often followed by chemotherapy (adjuvant chemotherapy).

Author(s): 
Lawrie, Theresa A.
Winter-Roach, Brett A.
Heus, Pauline
Kitchener, Henry C.
Publication Title: 
Journal of Psychiatric Research

Proopiomelanocortin (POMC) and its derived peptides, in particular alpha-MSH, have been shown to play a crucial role in the regulation of hunger, satiety and energy homeostasis. Studies in patients with anorexia nervosa (AN) suggest an abnormal expression of appetite-regulating hormones. Hormone expression levels may be modulated by epigenetic mechanisms, which were recently shown to be implicated in the pathophysiology of eating disorders.

Author(s): 
Ehrlich, Stefan
Weiss, Deike
Burghardt, Roland
Infante-Duarte, Carmen
Brockhaus, Simone
Muschler, Marc A.
Bleich, Stefan
Lehmkuhl, Ulrike
Frieling, Helge
Publication Title: 
Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer

PURPOSE: Psychological responses to cancer are widely believed to affect survival. We investigated associations between hope, optimism, anxiety, depression, health utility and survival in patients starting first-line chemotherapy for metastatic colorectal cancer. METHODS: Four hundred twenty-nine subjects with metastatic colorectal cancer in a randomised controlled trial of chemotherapy completed baseline questionnaires assessing the following: hopefulness, optimism, anxiety and depression and health utility.

Author(s): 
Schofield, Penelope E.
Stockler, M. R.
Zannino, D.
Tebbutt, N. C.
Price, T. J.
Simes, R. J.
Wong, N.
Pavlakis, N.
Ransom, D.
Moylan, E.
Underhill, C.
Wyld, D.
Burns, I.
Ward, R.
Wilcken, N.
Jefford, M.
Publication Title: 
The American Journal of Tropical Medicine and Hygiene

The efficacy of artemisinin monotherapy was studied in 227 patients with uncomplicated falciparum malaria. They all received artemisinin at t = 0 hr, t = 8 hr, and thereafter once daily; treatment was extended at random until they had taken either 5 days of artemisinin followed by 2 days of placebo (A5), or 7 days (A7) of artemisinin. The adult artemisinin dose was 500 mg; children aged < 15 years received 10 mg/kg per dose. The median (range) parasite clearance time was 39 (8-112) hr for A5 and 43 (38-104) hr for A7 (P = 0.085). The recrudescence rates were similar between the groups.

Author(s): 
Giao, P. T.
Binh, T. Q.
Kager, P. A.
Long, H. P.
Van Thang, N.
Van Nam, N.
de Vries, P. J.
Publication Title: 
Mayo Clinic Proceedings

OBJECTIVE: To determine the effect of intercessory prayer, a widely practiced complementary therapy, on cardiovascular disease progression after hospital discharge. PATIENTS AND METHODS: In this randomized controlled trial conducted between 1997 and 1999, a total of 799 coronary care unit patients were randomized at hospital discharge to the intercessory prayer group or to the control group. Intercessory prayer, ie, prayer by 1 or more persons on behalf of another, was administered at least once a week for 26 weeks by 5 intercessors per patient.

Author(s): 
Aviles, J. M.
Whelan, S. E.
Hernke, D. A.
Williams, B. A.
Kenny, K. E.
O'Fallon, W. M.
Kopecky, S. L.
Publication Title: 
Mayo Clinic Proceedings

OBJECTIVE: To determine the effect of intercessory prayer, a widely practiced complementary therapy, on cardiovascular disease progression after hospital discharge. PATIENTS AND METHODS: In this randomized controlled trial conducted between 1997 and 1999, a total of 799 coronary care unit patients were randomized at hospital discharge to the intercessory prayer group or to the control group. Intercessory prayer, ie, prayer by 1 or more persons on behalf of another, was administered at least once a week for 26 weeks by 5 intercessors per patient.

Author(s): 
Aviles, J. M.
Whelan, S. E.
Hernke, D. A.
Williams, B. A.
Kenny, K. E.
O'Fallon, W. M.
Kopecky, S. L.
Publication Title: 
Cancer Immunity

A differentiation antigen commonly expressed on melanoma cells, gp100 is the target of infiltrating T cells. We conducted a phase I randomized cross-over trial of melanoma patients with either xenogeneic (mouse) or human gp100 plasmid DNA injected intramuscularly at three dosages (100, 500 or 1,500 microg) every three weeks for three doses. After the first three injections, patients were then immunized three times with gp100 from the other species.

Author(s): 
Yuan, Jianda
Ku, Geoffrey Y.
Gallardo, Humilidad F.
Orlandi, Francesca
Manukian, Gregor
Rasalan, Teresa S.
Xu, Yinyan
Li, Hao
Vyas, Shachi
Mu, Zhenyu
Chapman, Paul B.
Krown, Susan E.
Panageas, Katherine
Terzulli, Stephanie L.
Old, Lloyd J.
Houghton, Alan N.
Wolchok, Jedd D.
Publication Title: 
Surgery

BACKGROUND: Neoadjuvant treatment has proven beneficial for many gastrointestinal (GI) malignancies, but no phase III trials have been completed examining this approach in pancreatic cancer. This meta-analysis examines the best available phase II trials using neoadjuvant treatment for resectable and borderline/unresectable pancreatic adenocarcinoma. METHODS: Phase II trials were identified using a MEDLINE search, and the Cochrane Central Register of Controlled Trials from 1960 to July 2010.

Author(s): 
Assifi, M. Mura
Lu, Xuyang
Eibl, Guido
Reber, Howard A.
Li, Gang
Hines, O. Joe
Publication Title: 
Biometrics

This article studies a semiparametric accelerated failure time mixture model for estimation of a biological treatment effect on a latent subgroup of interest with a time-to-event outcome in randomized clinical trials. Latency is induced because membership is observable in one arm of the trial and unidentified in the other.

Author(s): 
Altstein, L.
Li, G.
Publication Title: 
Annals of oncology: official journal of the European Society for Medical Oncology / ESMO

BACKGROUND: To evaluate the long-term needs of lung cancer survivors and to explore factors associated with unmet need. PATIENTS AND METHODS: We recruited lung patients treated with curative surgery from 2001 through 2006 at two centers in Korea. Needs in the domains of information, supportive care, education and counseling, and socioeconomic support were measured. We selected the four most frequently reported items of unmet need among 19 items in four domains.

Author(s): 
Yun, Y. H.
Shon, E.-J.
Yang, A.-J.
Kim, S. H.
Kim, Y. A.
Chang, Y. J.
Lee, J.
Kim, M. S.
Lee, H.-S.
Zo, J. I.
Kim, J.
Choi, Y. S.
Shim, Y. M.

Pages

Subscribe to RSS - Disease-Free Survival